News

CrossBridge Bio, Inc., a pre-clinical biotechnology company pioneering the development of next-generation dual-payload antibody-drug conjugates (ADCs) today announced a definitive agreement to be acquired by Eli Lilly and Company (“Lilly”).

For medical device startups, funding is never far from mind. A device doesn’t make the leap from a design on paper to a patient’s bedside without the right financial backing.

Surf Therapeutics, a clinical-stage neuro-immunomodulation company developing non-invasive ultrasound therapy for chronic inflammatory diseases, is announcing the start of an Early Feasibility Study evaluating its investigational ultrasound device in people living with rheumatoid arthritis.

Prana Surgical, a Houston-based medical device company, today announced the completion of the first five clinical procedures using the Prana System™ as part of its early feasibility study in Australia. The Prana System™ has been developed to enable image-guided, minimally invasive surgery, conserving healthy tissue and driving personalized treatment plans in a range of conditions,

Cadwell, a global leader in neurodiagnostic and monitoring solutions, and Medical Informatics Corp (MIC), creators of the Sickbay Clinical Platform, today announced a strategic partnership that aims to bring a new standard of integrated data and monitoring to hospitals. As part of the agreement, Cadwell systems will be the first neurodiagnostic product integrated with Sickbay’s

With consumer-grade self-scheduling, waitlist offers, and more, patients have easier access to world-class care close to home. Fisher-Titus Medical Center, a leading local health system offering the full continuum of care services to more than 70,000 patients in northern Ohio, deployed the Luma Health platform across 17 departments and multiple service lines to provide more